APO Research
Talk to an analyst

APO RESEARCH · REPORT

Interleukin 1 (IL1)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Interleukin 1 (IL1) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025198 pages

Choose your research edition.

Industry ResearchInterleukin 1 (IL1) Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Interleukin 1 (IL1) Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Interleukin 1 (IL1) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Interleukin 1 (IL1) Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Interleukin 1 (IL1) Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Interleukin 1 (IL1) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Interleukin 1 (IL1) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Interleukin 1 (IL1) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Interleukin 1 (IL1) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Interleukin 1 (IL1) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Interleukin 1 (IL1) include Novartis AG, AbbVie Inc, XBiotech Inc, TWi Biotechnology Inc, Swedish Orphan Biovitrum AB, Regeneron Pharmaceuticals Inc, R Pharm, Peptinov SAS and Orphit SAS, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Interleukin 1 (IL1) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Interleukin 1 (IL1) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Interleukin 1 (IL1) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Interleukin 1 (IL1) market size, projected growth trends, production technologies, key applications, and end-use industries.

Interleukin 1 (IL1) Segment by Company

Novartis AG

AbbVie Inc

XBiotech Inc

TWi Biotechnology Inc

Swedish Orphan Biovitrum AB

Regeneron Pharmaceuticals Inc

R Pharm

Peptinov SAS

Orphit SAS

Optimum Therapeutics LLC

Opsona Therapeutics Ltd

Omnitura Therapeutics Inc

Immune Response BioPharma Inc

Exicure Inc

Cell Medica Ltd

Apexigen Inc

Anacor Pharmaceuticals Inc

Interleukin 1 (IL1) Segment by Type

APX-002

Diacerein CR

Canakinumab

IR-1000

Others

Interleukin 1 (IL1) Segment by Application

Fallopian Tube Cancer

Esophageal Cancer

Bechcer Disease

Bladder Cancer

Others

Interleukin 1 (IL1) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Interleukin 1 (IL1) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Interleukin 1 (IL1) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Interleukin 1 (IL1).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Interleukin 1 (IL1) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Interleukin 1 (IL1) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Interleukin 1 (IL1) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Interleukin 1 (IL1) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Interleukin 1 (IL1) Industry Trends Table 2. Interleukin 1 (IL1) Industry Drivers Table 3. Interleukin 1 (IL1) Industry Opportunities and Challenges Table 4. Interleukin 1 (IL1) Industry Restraints Table 5. Global Interleukin 1 (IL1) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Interleukin 1 (IL1) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Interleukin 1 (IL1) Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Interleukin 1 (IL1) Sales Market Share by Manufacturers Table 9. Global Interleukin 1 (IL1) Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Interleukin 1 (IL1) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Interleukin 1 (IL1) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Interleukin 1 (IL1) Manufacturers, Product Type & Application Table 13. Global Interleukin 1 (IL1) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Interleukin 1 (IL1) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of APX-002 Table 17. Major Manufacturers of Diacerein CR Table 18. Major Manufacturers of Canakinumab Table 19. Major Manufacturers of IR-1000 Table 20. Major Manufacturers of Others Table 21. Global Interleukin 1 (IL1) Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Interleukin 1 (IL1) Sales by Type (2021-2026) & (K Units) Table 23. Global Interleukin 1 (IL1) Sales by Type (2027-2032) & (K Units) Table 24. Global Interleukin 1 (IL1) Sales Market Share by Type (2021-2026) Table 25. Global Interleukin 1 (IL1) Sales Market Share by Type (2027-2032) Table 26. Global Interleukin 1 (IL1) Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Interleukin 1 (IL1) Revenue by Type (2021-2026) & (K Units) Table 28. Global Interleukin 1 (IL1) Revenue by Type (2027-2032) & (K Units) Table 29. Global Interleukin 1 (IL1) Revenue Market Share by Type (2021-2026) Table 30. Global Interleukin 1 (IL1) Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Fallopian Tube Cancer Table 32. Major Manufacturers of Esophageal Cancer Table 33. Major Manufacturers of Bechcer Disease Table 34. Major Manufacturers of Bladder Cancer Table 35. Major Manufacturers of Others Table 36. Global Interleukin 1 (IL1) Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Interleukin 1 (IL1) Sales by Application (2021-2026) & (K Units) Table 38. Global Interleukin 1 (IL1) Sales by Application (2027-2032) & (K Units) Table 39. Global Interleukin 1 (IL1) Sales Market Share by Application (2021-2026) Table 40. Global Interleukin 1 (IL1) Sales Market Share by Application (2027-2032) Table 41. Global Interleukin 1 (IL1) Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 42. Global Interleukin 1 (IL1) Revenue by Application (2021-2026) & (K Units) Table 43. Global Interleukin 1 (IL1) Revenue by Application (2027-2032) & (K Units) Table 44. Global Interleukin 1 (IL1) Revenue Market Share by Application (2021-2026) Table 45. Global Interleukin 1 (IL1) Revenue Market Share by Application (2027-2032) Table 46. Global Interleukin 1 (IL1) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 47. Global Interleukin 1 (IL1) Sales by Region (2021-2026) & (K Units) Table 48. Global Interleukin 1 (IL1) Sales Market Share by Region (2021-2026) Table 49. Global Interleukin 1 (IL1) Sales Forecasted by Region (2027-2032) & (K Units) Table 50. Global Interleukin 1 (IL1) Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Interleukin 1 (IL1) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. North America Interleukin 1 (IL1) Sales by Country (2021-2026) & (K Units) Table 53. North America Interleukin 1 (IL1) Sales by Country (2027-2032) & (K Units) Table 54. Europe Interleukin 1 (IL1) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Europe Interleukin 1 (IL1) Sales by Country (2021-2026) & (K Units) Table 56. Europe Interleukin 1 (IL1) Sales by Country (2027-2032) & (K Units) Table 57. Asia Pacific Interleukin 1 (IL1) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Asia Pacific Interleukin 1 (IL1) Sales by Country (2021-2026) & (K Units) Table 59. Asia Pacific Interleukin 1 (IL1) Sales by Country (2027-2032) & (K Units) Table 60. South America, Middle East and Africa Interleukin 1 (IL1) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 61. South America, Middle East and Africa Interleukin 1 (IL1) Sales by Country (2021-2026) & (K Units) Table 62. South America, Middle East and Africa Interleukin 1 (IL1) Sales by Country (2027-2032) & (K Units) Table 63. Global Interleukin 1 (IL1) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Interleukin 1 (IL1) Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Interleukin 1 (IL1) Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Interleukin 1 (IL1) Revenue Market Share by Region (2021-2026) Table 67. Global Interleukin 1 (IL1) Revenue Market Share by Region (2027-2032) Table 68. Novartis AG Company Information Table 69. Novartis AG Business Overview Table 70. Novartis AG Interleukin 1 (IL1) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Novartis AG Interleukin 1 (IL1) Product Portfolio Table 72. Novartis AG Recent Development Table 73. AbbVie Inc Company Information Table 74. AbbVie Inc Business Overview Table 75. AbbVie Inc Interleukin 1 (IL1) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. AbbVie Inc Interleukin 1 (IL1) Product Portfolio Table 77. AbbVie Inc Recent Development Table 78. XBiotech Inc Company Information Table 79. XBiotech Inc Business Overview Table 80. XBiotech Inc Interleukin 1 (IL1) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. XBiotech Inc Interleukin 1 (IL1) Product Portfolio Table 82. XBiotech Inc Recent Development Table 83. TWi Biotechnology Inc Company Information Table 84. TWi Biotechnology Inc Business Overview Table 85. TWi Biotechnology Inc Interleukin 1 (IL1) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. TWi Biotechnology Inc Interleukin 1 (IL1) Product Portfolio Table 87. TWi Biotechnology Inc Recent Development Table 88. Swedish Orphan Biovitrum AB Company Information Table 89. Swedish Orphan Biovitrum AB Business Overview Table 90. Swedish Orphan Biovitrum AB Interleukin 1 (IL1) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Swedish Orphan Biovitrum AB Interleukin 1 (IL1) Product Portfolio Table 92. Swedish Orphan Biovitrum AB Recent Development Table 93. Regeneron Pharmaceuticals Inc Company Information Table 94. Regeneron Pharmaceuticals Inc Business Overview Table 95. Regeneron Pharmaceuticals Inc Interleukin 1 (IL1) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Regeneron Pharmaceuticals Inc Interleukin 1 (IL1) Product Portfolio Table 97. Regeneron Pharmaceuticals Inc Recent Development Table 98. R Pharm Company Information Table 99. R Pharm Business Overview Table 100. R Pharm Interleukin 1 (IL1) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. R Pharm Interleukin 1 (IL1) Product Portfolio Table 102. R Pharm Recent Development Table 103. Peptinov SAS Company Information Table 104. Peptinov SAS Business Overview Table 105. Peptinov SAS Interleukin 1 (IL1) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Peptinov SAS Interleukin 1 (IL1) Product Portfolio Table 107. Peptinov SAS Recent Development Table 108. Orphit SAS Company Information Table 109. Orphit SAS Business Overview Table 110. Orphit SAS Interleukin 1 (IL1) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Orphit SAS Interleukin 1 (IL1) Product Portfolio Table 112. Orphit SAS Recent Development Table 113. Optimum Therapeutics LLC Company Information Table 114. Optimum Therapeutics LLC Business Overview Table 115. Optimum Therapeutics LLC Interleukin 1 (IL1) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Optimum Therapeutics LLC Interleukin 1 (IL1) Product Portfolio Table 117. Optimum Therapeutics LLC Recent Development Table 118. Opsona Therapeutics Ltd Company Information Table 119. Opsona Therapeutics Ltd Business Overview Table 120. Opsona Therapeutics Ltd Interleukin 1 (IL1) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Opsona Therapeutics Ltd Interleukin 1 (IL1) Product Portfolio Table 122. Opsona Therapeutics Ltd Recent Development Table 123. Omnitura Therapeutics Inc Company Information Table 124. Omnitura Therapeutics Inc Business Overview Table 125. Omnitura Therapeutics Inc Interleukin 1 (IL1) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Omnitura Therapeutics Inc Interleukin 1 (IL1) Product Portfolio Table 127. Omnitura Therapeutics Inc Recent Development Table 128. Immune Response BioPharma Inc Company Information Table 129. Immune Response BioPharma Inc Business Overview Table 130. Immune Response BioPharma Inc Interleukin 1 (IL1) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Immune Response BioPharma Inc Interleukin 1 (IL1) Product Portfolio Table 132. Immune Response BioPharma Inc Recent Development Table 133. Exicure Inc Company Information Table 134. Exicure Inc Business Overview Table 135. Exicure Inc Interleukin 1 (IL1) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Exicure Inc Interleukin 1 (IL1) Product Portfolio Table 137. Exicure Inc Recent Development Table 138. Cell Medica Ltd Company Information Table 139. Cell Medica Ltd Business Overview Table 140. Cell Medica Ltd Interleukin 1 (IL1) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Cell Medica Ltd Interleukin 1 (IL1) Product Portfolio Table 142. Cell Medica Ltd Recent Development Table 143. Apexigen Inc Company Information Table 144. Apexigen Inc Business Overview Table 145. Apexigen Inc Interleukin 1 (IL1) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Apexigen Inc Interleukin 1 (IL1) Product Portfolio Table 147. Apexigen Inc Recent Development Table 148. Anacor Pharmaceuticals Inc Company Information Table 149. Anacor Pharmaceuticals Inc Business Overview Table 150. Anacor Pharmaceuticals Inc Interleukin 1 (IL1) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. Anacor Pharmaceuticals Inc Interleukin 1 (IL1) Product Portfolio Table 152. Anacor Pharmaceuticals Inc Recent Development Table 153. Key Raw Materials Table 154. Raw Materials Key Suppliers Table 155. Interleukin 1 (IL1) Distributors List Table 156. Interleukin 1 (IL1) Customers List Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Interleukin 1 (IL1) Product Image Figure 2. Global Interleukin 1 (IL1) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Interleukin 1 (IL1) Market Size (2021-2032) & (US$ Million) Figure 4. Global Interleukin 1 (IL1) Sales (2021-2032) & (K Units) Figure 5. Global Interleukin 1 (IL1) Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Interleukin 1 (IL1) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. APX-002 Image Figure 9. Diacerein CR Image Figure 10. Canakinumab Image Figure 11. IR-1000 Image Figure 12. Others Image Figure 13. Global Interleukin 1 (IL1) Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Interleukin 1 (IL1) Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Interleukin 1 (IL1) Sales Market Share by Type (2021-2032) Figure 16. Global Interleukin 1 (IL1) Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Interleukin 1 (IL1) Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Interleukin 1 (IL1) Revenue Market Share by Type (2021-2032) Figure 19. Fallopian Tube Cancer Image Figure 20. Esophageal Cancer Image Figure 21. Bechcer Disease Image Figure 22. Bladder Cancer Image Figure 23. Others Image Figure 24. Global Interleukin 1 (IL1) Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Interleukin 1 (IL1) Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Interleukin 1 (IL1) Sales Market Share by Application (2021-2032) Figure 27. Global Interleukin 1 (IL1) Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 28. Global Interleukin 1 (IL1) Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Interleukin 1 (IL1) Revenue Market Share by Application (2021-2032) Figure 30. North America Interleukin 1 (IL1) Sales and Growth Rate (2021-2032) & (K Units) Figure 31. North America Interleukin 1 (IL1) Sales Market Share by Country (2021-2032) Figure 32. U.S. Interleukin 1 (IL1) Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Canada Interleukin 1 (IL1) Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Mexico Interleukin 1 (IL1) Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe Interleukin 1 (IL1) Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Europe Interleukin 1 (IL1) Sales Market Share by Country (2021-2032) Figure 37. Germany Interleukin 1 (IL1) Sales and Growth Rate (2021-2032) & (K Units) Figure 38. France Interleukin 1 (IL1) Sales and Growth Rate (2021-2032) & (K Units) Figure 39. U.K. Interleukin 1 (IL1) Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Italy Interleukin 1 (IL1) Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Netherlands Interleukin 1 (IL1) Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific Interleukin 1 (IL1) Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Asia Pacific Interleukin 1 (IL1) Sales Market Share by Country (2021-2032) Figure 44. China Interleukin 1 (IL1) Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Japan Interleukin 1 (IL1) Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South Korea Interleukin 1 (IL1) Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Southeast Asia Interleukin 1 (IL1) Sales and Growth Rate (2021-2032) & (K Units) Figure 48. India Interleukin 1 (IL1) Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Australia Interleukin 1 (IL1) Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa Interleukin 1 (IL1) Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South America, Middle East and Africa Interleukin 1 (IL1) Sales Market Share by Country (2021-2032) Figure 52. Brazil Interleukin 1 (IL1) Sales and Growth Rate (2021-2032) & (K Units) Figure 53. South Africa Interleukin 1 (IL1) Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Saudi Arabia Interleukin 1 (IL1) Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Turkey Interleukin 1 (IL1) Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Argentina Interleukin 1 (IL1) Sales and Growth Rate (2021-2032) & (K Units) Figure 57. UAE Interleukin 1 (IL1) Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Egypt Interleukin 1 (IL1) Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Chile Interleukin 1 (IL1) Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Global Interleukin 1 (IL1) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Interleukin 1 (IL1) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Interleukin 1 (IL1) Revenue (2021-2032) & (US$ Million) Figure 63. North America Interleukin 1 (IL1) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Interleukin 1 (IL1) Revenue (2021-2032) & (US$ Million) Figure 65. Europe Interleukin 1 (IL1) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Interleukin 1 (IL1) Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Interleukin 1 (IL1) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Interleukin 1 (IL1) Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Interleukin 1 (IL1) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Interleukin 1 (IL1) Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Interleukin 1 (IL1) Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • APX-002
  • Diacerein CR
  • Canakinumab
  • IR-1000
  • Others
Applications
  • Fallopian Tube Cancer
  • Esophageal Cancer
  • Bechcer Disease
  • Bladder Cancer
  • Others
Companies covered
  • Novartis AG
  • AbbVie Inc
  • XBiotech Inc
  • TWi Biotechnology Inc
  • Swedish Orphan Biovitrum AB
  • Regeneron Pharmaceuticals Inc
  • R Pharm
  • Peptinov SAS
  • Orphit SAS
  • Optimum Therapeutics LLC
  • Opsona Therapeutics Ltd
  • Omnitura Therapeutics Inc
  • Immune Response BioPharma Inc
  • Exicure Inc
  • Cell Medica Ltd
  • Apexigen Inc
  • Anacor Pharmaceuticals Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Interleukin 1 (IL1) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Interleukin 1 (IL1) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Interleukin 1 (IL1) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Interleukin 1 (IL1) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Interleukin 1 (IL1) Market Dynamics
  1. 2.1 Interleukin 1 (IL1) Industry Trends
  2. 2.2 Interleukin 1 (IL1) Industry Drivers
  3. 2.3 Interleukin 1 (IL1) Industry Opportunities and Challenges
  4. 2.4 Interleukin 1 (IL1) Industry Restraints
3 Interleukin 1 (IL1) Market by Manufacturers
  1. 3.1 Global Interleukin 1 (IL1) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Interleukin 1 (IL1) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Interleukin 1 (IL1) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Interleukin 1 (IL1) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Interleukin 1 (IL1) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Interleukin 1 (IL1) Manufacturers, Product Type & Application
  7. 3.7 Global Interleukin 1 (IL1) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Interleukin 1 (IL1) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Interleukin 1 (IL1) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Interleukin 1 (IL1) Tier 1, Tier 2, and Tier 3
4 Interleukin 1 (IL1) Market by Type
  1. 4.1 Interleukin 1 (IL1) Type Introduction
  2. 4.1.1 APX-002
  3. 4.1.2 Diacerein CR
  4. 4.1.3 Canakinumab
  5. 4.1.4 IR-1000
  6. 4.1.5 Others
  7. 4.2 Global Interleukin 1 (IL1) Sales by Type
  8. 4.2.1 Global Interleukin 1 (IL1) Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Interleukin 1 (IL1) Sales by Type (2021-2032)
  10. 4.2.3 Global Interleukin 1 (IL1) Sales Market Share by Type (2021-2032)
  11. 4.3 Global Interleukin 1 (IL1) Revenue by Type
  12. 4.3.1 Global Interleukin 1 (IL1) Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Interleukin 1 (IL1) Revenue by Type (2021-2032)
  14. 4.3.3 Global Interleukin 1 (IL1) Revenue Market Share by Type (2021-2032)
5 Interleukin 1 (IL1) Market by Application
  1. 5.1 Interleukin 1 (IL1) Application Introduction
  2. 5.1.1 Fallopian Tube Cancer
  3. 5.1.2 Esophageal Cancer
  4. 5.1.3 Bechcer Disease
  5. 5.1.4 Bladder Cancer
  6. 5.1.5 Others
  7. 5.2 Global Interleukin 1 (IL1) Sales by Application
  8. 5.2.1 Global Interleukin 1 (IL1) Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Interleukin 1 (IL1) Sales by Application (2021-2032)
  10. 5.2.3 Global Interleukin 1 (IL1) Sales Market Share by Application (2021-2032)
  11. 5.3 Global Interleukin 1 (IL1) Revenue by Application
  12. 5.3.1 Global Interleukin 1 (IL1) Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Interleukin 1 (IL1) Revenue by Application (2021-2032)
  14. 5.3.3 Global Interleukin 1 (IL1) Revenue Market Share by Application (2021-2032)
6 Global Interleukin 1 (IL1) Sales by Region
  1. 6.1 Global Interleukin 1 (IL1) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Interleukin 1 (IL1) Sales by Region (2021-2032)
  3. 6.2.1 Global Interleukin 1 (IL1) Sales by Region (2021-2026)
  4. 6.2.2 Global Interleukin 1 (IL1) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Interleukin 1 (IL1) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Interleukin 1 (IL1) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Interleukin 1 (IL1) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Interleukin 1 (IL1) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Interleukin 1 (IL1) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Interleukin 1 (IL1) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Interleukin 1 (IL1) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Interleukin 1 (IL1) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Interleukin 1 (IL1) Revenue by Region
  1. 7.1 Global Interleukin 1 (IL1) Revenue by Region
  2. 7.1.1 Global Interleukin 1 (IL1) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Interleukin 1 (IL1) Revenue by Region (2021-2026)
  4. 7.1.3 Global Interleukin 1 (IL1) Revenue by Region (2027-2032)
  5. 7.1.4 Global Interleukin 1 (IL1) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Interleukin 1 (IL1) Revenue (2021-2032)
  8. 7.2.2 North America Interleukin 1 (IL1) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Interleukin 1 (IL1) Revenue (2021-2032)
  11. 7.3.2 Europe Interleukin 1 (IL1) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Interleukin 1 (IL1) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Interleukin 1 (IL1) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Interleukin 1 (IL1) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Interleukin 1 (IL1) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis AG
  2. 8.1.1 Novartis AG Company Information
  3. 8.1.2 Novartis AG Business Overview
  4. 8.1.3 Novartis AG Interleukin 1 (IL1) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Novartis AG Interleukin 1 (IL1) Product Portfolio
  6. 8.1.5 Novartis AG Recent Developments
  7. 8.2 AbbVie Inc
  8. 8.2.1 AbbVie Inc Company Information
  9. 8.2.2 AbbVie Inc Business Overview
  10. 8.2.3 AbbVie Inc Interleukin 1 (IL1) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 AbbVie Inc Interleukin 1 (IL1) Product Portfolio
  12. 8.2.5 AbbVie Inc Recent Developments
  13. 8.3 XBiotech Inc
  14. 8.3.1 XBiotech Inc Company Information
  15. 8.3.2 XBiotech Inc Business Overview
  16. 8.3.3 XBiotech Inc Interleukin 1 (IL1) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 XBiotech Inc Interleukin 1 (IL1) Product Portfolio
  18. 8.3.5 XBiotech Inc Recent Developments
  19. 8.4 TWi Biotechnology Inc
  20. 8.4.1 TWi Biotechnology Inc Company Information
  21. 8.4.2 TWi Biotechnology Inc Business Overview
  22. 8.4.3 TWi Biotechnology Inc Interleukin 1 (IL1) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 TWi Biotechnology Inc Interleukin 1 (IL1) Product Portfolio
  24. 8.4.5 TWi Biotechnology Inc Recent Developments
  25. 8.5 Swedish Orphan Biovitrum AB
  26. 8.5.1 Swedish Orphan Biovitrum AB Company Information
  27. 8.5.2 Swedish Orphan Biovitrum AB Business Overview
  28. 8.5.3 Swedish Orphan Biovitrum AB Interleukin 1 (IL1) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Swedish Orphan Biovitrum AB Interleukin 1 (IL1) Product Portfolio
  30. 8.5.5 Swedish Orphan Biovitrum AB Recent Developments
  31. 8.6 Regeneron Pharmaceuticals Inc
  32. 8.6.1 Regeneron Pharmaceuticals Inc Company Information
  33. 8.6.2 Regeneron Pharmaceuticals Inc Business Overview
  34. 8.6.3 Regeneron Pharmaceuticals Inc Interleukin 1 (IL1) Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Regeneron Pharmaceuticals Inc Interleukin 1 (IL1) Product Portfolio
  36. 8.6.5 Regeneron Pharmaceuticals Inc Recent Developments
  37. 8.7 R Pharm
  38. 8.7.1 R Pharm Company Information
  39. 8.7.2 R Pharm Business Overview
  40. 8.7.3 R Pharm Interleukin 1 (IL1) Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 R Pharm Interleukin 1 (IL1) Product Portfolio
  42. 8.7.5 R Pharm Recent Developments
  43. 8.8 Peptinov SAS
  44. 8.8.1 Peptinov SAS Company Information
  45. 8.8.2 Peptinov SAS Business Overview
  46. 8.8.3 Peptinov SAS Interleukin 1 (IL1) Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Peptinov SAS Interleukin 1 (IL1) Product Portfolio
  48. 8.8.5 Peptinov SAS Recent Developments
  49. 8.9 Orphit SAS
  50. 8.9.1 Orphit SAS Company Information
  51. 8.9.2 Orphit SAS Business Overview
  52. 8.9.3 Orphit SAS Interleukin 1 (IL1) Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Orphit SAS Interleukin 1 (IL1) Product Portfolio
  54. 8.9.5 Orphit SAS Recent Developments
  55. 8.10 Optimum Therapeutics LLC
  56. 8.10.1 Optimum Therapeutics LLC Company Information
  57. 8.10.2 Optimum Therapeutics LLC Business Overview
  58. 8.10.3 Optimum Therapeutics LLC Interleukin 1 (IL1) Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Optimum Therapeutics LLC Interleukin 1 (IL1) Product Portfolio
  60. 8.10.5 Optimum Therapeutics LLC Recent Developments
  61. 8.11 Opsona Therapeutics Ltd
  62. 8.11.1 Opsona Therapeutics Ltd Company Information
  63. 8.11.2 Opsona Therapeutics Ltd Business Overview
  64. 8.11.3 Opsona Therapeutics Ltd Interleukin 1 (IL1) Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Opsona Therapeutics Ltd Interleukin 1 (IL1) Product Portfolio
  66. 8.11.5 Opsona Therapeutics Ltd Recent Developments
  67. 8.12 Omnitura Therapeutics Inc
  68. 8.12.1 Omnitura Therapeutics Inc Company Information
  69. 8.12.2 Omnitura Therapeutics Inc Business Overview
  70. 8.12.3 Omnitura Therapeutics Inc Interleukin 1 (IL1) Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Omnitura Therapeutics Inc Interleukin 1 (IL1) Product Portfolio
  72. 8.12.5 Omnitura Therapeutics Inc Recent Developments
  73. 8.13 Immune Response BioPharma Inc
  74. 8.13.1 Immune Response BioPharma Inc Company Information
  75. 8.13.2 Immune Response BioPharma Inc Business Overview
  76. 8.13.3 Immune Response BioPharma Inc Interleukin 1 (IL1) Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Immune Response BioPharma Inc Interleukin 1 (IL1) Product Portfolio
  78. 8.13.5 Immune Response BioPharma Inc Recent Developments
  79. 8.14 Exicure Inc
  80. 8.14.1 Exicure Inc Company Information
  81. 8.14.2 Exicure Inc Business Overview
  82. 8.14.3 Exicure Inc Interleukin 1 (IL1) Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Exicure Inc Interleukin 1 (IL1) Product Portfolio
  84. 8.14.5 Exicure Inc Recent Developments
  85. 8.15 Cell Medica Ltd
  86. 8.15.1 Cell Medica Ltd Company Information
  87. 8.15.2 Cell Medica Ltd Business Overview
  88. 8.15.3 Cell Medica Ltd Interleukin 1 (IL1) Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Cell Medica Ltd Interleukin 1 (IL1) Product Portfolio
  90. 8.15.5 Cell Medica Ltd Recent Developments
  91. 8.16 Apexigen Inc
  92. 8.16.1 Apexigen Inc Company Information
  93. 8.16.2 Apexigen Inc Business Overview
  94. 8.16.3 Apexigen Inc Interleukin 1 (IL1) Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Apexigen Inc Interleukin 1 (IL1) Product Portfolio
  96. 8.16.5 Apexigen Inc Recent Developments
  97. 8.17 Anacor Pharmaceuticals Inc
  98. 8.17.1 Anacor Pharmaceuticals Inc Company Information
  99. 8.17.2 Anacor Pharmaceuticals Inc Business Overview
  100. 8.17.3 Anacor Pharmaceuticals Inc Interleukin 1 (IL1) Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Anacor Pharmaceuticals Inc Interleukin 1 (IL1) Product Portfolio
  102. 8.17.5 Anacor Pharmaceuticals Inc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Interleukin 1 (IL1) Value Chain Analysis
  2. 9.1.1 Interleukin 1 (IL1) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Interleukin 1 (IL1) Production Mode & Process
  6. 9.2 Interleukin 1 (IL1) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Interleukin 1 (IL1) Distributors
  9. 9.2.3 Interleukin 1 (IL1) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst